NCT04148690

Brief Summary

Group antenatal care (GANC) is a service delivery model where women with pregnancies of similar gestational age are brought together for antenatal care (ANC), incorporating information sharing and peer support. This model provides selected aspects of clinical care to women in the group at the same time during group visits, as well as creating a support group of women at a similar stage in pregnancy, to improve the quality of care and engagement of women in the ANC process, ultimately leading to better retention in care. Initial studies have suggested that this improves uptake of intermittent preventive treatment in pregnancy (IPTp) among women who participate, but have not evaluated the effect at community level. The investigators propose to assess whether use of the GANC model in Tanzania can improve the quality of ANC as compared to standard individual ANC, by measuring uptake of recommended interventions, primarily IPTp. Recent data from Tanzania and Kenya suggest that malaria parasitemia prevalence among pregnant women correlates with the prevalence among children under five, and could be used to track trends over time.3-5 The very high coverage of ANC (\>80% attending at least one ANC contact), suggests that pregnant women could be a good sentinel population that could be readily tracked over time. However, pregnant women represent only about 5% of the overall population, thus, it is important to demonstrate that the trends in malaria prevalence and household level coverage of interventions reported by pregnant women attending ANC is representative of coverage among the general population. If validated, these data could be used to augment or even replace the data on coverage of interventions collected through the use of malaria indicator surveys, which are expensive and infrequently conducted, and generally only powered to the regional level.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,515

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 1, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

November 15, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2021

Completed
Last Updated

July 29, 2021

Status Verified

July 1, 2021

Enrollment Period

1.7 years

First QC Date

October 25, 2019

Last Update Submit

July 22, 2021

Conditions

Keywords

Group antenatal careSurveillanceTanzaniaMalaria in Pregnancy

Outcome Measures

Primary Outcomes (2)

  • Change in proportion of recently pregnant women receiving IPTp3

    Proportion of recently pregnant women receiving IPTp3 as measured by cross sectional household surveys

    Change between 0 and 18 months of implementation

  • Correlation between ANC data and population data

    Correlation between ANC data and population data collected during cross sectional survey on ITN ownership and care seeking behavior among children

    Through study completion, an average of 1 year

Secondary Outcomes (7)

  • Change in ANC coverage

    Change between 0 and 18 months of implementation

  • Change in Gestational age at initiation of ANC

    Change between 0 and 18 months of implementation

  • Change in Proportion of women who recently gave birth who received blood pressure, urine test, blood test, tetanus, IFA, albendazole, ITN, and IPTp

    Change between 0 and 18 months of implementation

  • Change in Proportion of women who recently gave birth who had a facility-based delivery as measured by cross sectional household surveys

    Change between 0 and 18 months of implementation

  • Prevalence of malaria by RDT among pregnant women attending 1st ANC

    throughout study period; average of once per month

  • +2 more secondary outcomes

Study Arms (2)

Group ANC Intervention

EXPERIMENTAL

Clinics in the group ANC intervention arm offer group Antenatal Care to women who present for their initial visit prior to 24 weeks provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. Women not enrolled in group ANC will receive standard ANC per ministry of health protocols.

Other: Group antenatal care (GANC)

Routine ANC

ACTIVE COMPARATOR

Clinics will offer only standard ANC per ministry of health protocols.

Other: Standard antenatal care

Interventions

Group antenatal care (GANC) is a service delivery model where women with pregnancies of similar gestational age are brought together for antenatal care (ANC), incorporating information sharing and peer support.

Group ANC Intervention

Routine antenatal care as recommended by th Ministry of Health of Tanzania

Routine ANC

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women residing in the facility catchment area, who present for initial ANC visit prior to 24 weeks are eligible to participate in GANC provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. All women attending first ANC at participating facilities will be asked to respond to a short list of questions regarding the coverage of malaria control interventions in their household.

You may not qualify if:

  • Pregnant women: Women will be excluded from participation in GANC if they initiate ANC care \>24 weeks gestation, if there are no available groups that they can join, if they do not intend to remain in the facility catchment area for the duration of the study, or if they are not available during the times the group intends to meet. Women will also be excluded if they do not speak Swahili, as group discussions will be conducted in Swahili.
  • Children between the ages of 6-59 months will be included provided that they are living in households interviewed during the baseline or end line cross sectional survey and a parent or legal guardian provides consent for their participation
  • Providers:
  • ANC provider who has had at least six months of work experience
  • Health facility in-charge
  • Health management information system (HMIS) focal person
  • Those who have been working in the health facility for less than six months will not be interviewed due to low levels of relevant experience or exposure to the intervention.
  • Policy makers:
  • In depth interviews may be conducted with program managers (malaria, reproductive health, and statistics/ data collection officers) at the district, regional and national levels
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chato District Hospital

Chato, Tanzania

Location

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Ruth Lemwayi, MD

    Jhpiego

    PRINCIPAL INVESTIGATOR
  • Julie R Gutman, MD MSc

    Centers for Disease Control and Prevention

    PRINCIPAL INVESTIGATOR
  • Mary Drake

    Jhpiego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
the outcomes will be assessed through conduct of a cross sectional survey; those conducting the survey will not be informed as to which arm the women were in
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This will be a cluster randomized controlled trial conducted over an 18-month period. Facilities will be randomized 1:1 to control and intervention arms.
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Officer, Strategic and Applied Science Unit, Malaria Branch

Study Record Dates

First Submitted

October 25, 2019

First Posted

November 1, 2019

Study Start

November 15, 2019

Primary Completion

July 10, 2021

Study Completion

July 10, 2021

Last Updated

July 29, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Individual participant data may only be made available upon specific request after appropriate approvals for data sharing have been granted by Tanzanian authorities

Locations